Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 2.67M | $1.0M | 9.50% | -- | 2026-06-30 |
| Acorn Capital Advisors, LLC | 1.44M | -- | 5.12% | +26.7K | 2026-06-30 |
| Kingdon Capital Management, L.L.C. | 1.35M | -- | 4.82% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 1.17M | -- | 4.17% | -576 | 2026-06-30 |
| Rock Springs Capital Management LP | 1.10M | -- | 3.92% | -- | 2026-06-30 |
| Carlyle Group Inc. | 1.07M | -- | 3.80% | -- | 2026-06-30 |
| Gsa Capital Partners LLP | 534.7K | -- | 1.90% | +515.6K | 2026-06-30 |
| Millennium Management LLC | 486.9K | -- | 1.73% | -1.13M | 2026-06-30 |
| Lion Point Capital, LP | 465.0K | -- | 1.66% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 263.8K | -- | 0.94% | -53.9K | 2026-06-30 |
